source
- FDA Approves Zenocutuzumab for NRG1 Fusion+ Cholangiocarcinomaonclive · 2mo ago↗ source
- UT MD Anderson Shares Latest Research BreakthroughsThe University of Texas MD Anderson Cancer Center released recent oncology research highlights.onclive · 2mo ago↗ source
- Lilly to invest extra $4.5B across Indiana manufacturingThe Indianapolis-based company expanded its spend to ensure it can meet growing demand for its weight-loss drugs.BioPharma Dive · 2mo ago↗ source